Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Vetro

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Non-Coding RNA|January 25, 2022
Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBCZhen Ye, Mai Mohamed Abdelmoaty, Stephen M Curran, et al.
International Journal of Pharmaceutics|May 12, 2019
Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infectionShailendra B Tallapaka, Bala V K Karuturi, Pravin Yeapuri, et al.
Toxicology and Applied Pharmacology|March 17, 2009
Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouseSatoko Kakiuchi-Kiyota, Joseph A Vetro, Shugo Suzuki, et al.
Pharmaceutics|September 23, 2022
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory ImmunizationJacob E Parriott, Jason P Stewart, D David Smith, et al.
Pharmaceutical Research|September 17, 2014
Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors after IV administrationRajesh R Wakaskar, Sai Praneeth R Bathena, Shailendra B Tallapaka, et al.
Nanomedicine (London, England)|April 1, 2011
Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cellsMatthew J Haney, Yuling Zhao, Shu Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 5, 2021
Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancerZhen Ye, Mai Mohamed Abdelmoaty, Vishakha V Ambardekar, et al.
Pharmaceutics|January 8, 2025
Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> USA300Jason P Stewart, Caleb M Sandall, Jacob E Parriott, et al.
ACS Infectious Diseases|April 3, 2020
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67Abdulraman M Alshammari, D David Smith, Jake Parriott, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Non-Coding RNA|January 25, 2022
Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBCZhen Ye, Mai Mohamed Abdelmoaty, Stephen M Curran, et al.
International Journal of Pharmaceutics|May 12, 2019
Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infectionShailendra B Tallapaka, Bala V K Karuturi, Pravin Yeapuri, et al.
Toxicology and Applied Pharmacology|March 17, 2009
Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouseSatoko Kakiuchi-Kiyota, Joseph A Vetro, Shugo Suzuki, et al.
Pharmaceutics|September 23, 2022
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory ImmunizationJacob E Parriott, Jason P Stewart, D David Smith, et al.
Pharmaceutical Research|September 17, 2014
Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors after IV administrationRajesh R Wakaskar, Sai Praneeth R Bathena, Shailendra B Tallapaka, et al.
Nanomedicine (London, England)|April 1, 2011
Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cellsMatthew J Haney, Yuling Zhao, Shu Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 5, 2021
Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancerZhen Ye, Mai Mohamed Abdelmoaty, Vishakha V Ambardekar, et al.
Pharmaceutics|January 8, 2025
Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> USA300Jason P Stewart, Caleb M Sandall, Jacob E Parriott, et al.
ACS Infectious Diseases|April 3, 2020
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67Abdulraman M Alshammari, D David Smith, Jake Parriott, et al.
Pageof 2